Using Automation to Enhance Manufacturing: Building the Foundation for Pharma 4.0

Automation has long been associated with consistent process execution and reliable equipment control. While these capabilities remain fundamental, the role of automation in pharmaceutical manufacturing has expanded significantly.

Today's manufacturers operate in an increasingly complex environment. They manage diverse product portfolios, scale new therapies, transfer processes across multiple sites, and respond to evolving regulatory and customer expectations. At the same time, every manufacturing decision—from production scheduling to deviation investigations—must be supported by accurate, reliable, and readily accessible information.^1,2.

Simply automating individual pieces of equipment is no longer sufficient. Modern pharmaceutical manufacturing requires connected operations where information flows seamlessly across production, engineering, quality, maintenance, and business systems. Manufacturers need the ability to detect issues earlier, respond faster, and make informed decisions based on trusted operational data rather than fragmented information.

Automation has therefore evolved into much more than a process control technology. It provides the digital foundation that enables connected manufacturing, strengthens data integrity, supports compliance, and prepares organizations for advanced technologies such as Industrial Internet of Things (IIoT), Electronic Batch Production Records (eBPR), artificial intelligence (AI), and ultimately Pharma 4.0.^1-4

Addressing the Growing Complexity of Pharmaceutical Manufacturing

Pharmaceutical manufacturing has always demanded precision. Every batch must consistently meet stringent quality standards while production teams balance efficiency, compliance, and operational reliability.^1,5.

As manufacturing environments become increasingly sophisticated, however, meeting these expectations has become more challenging. Facilities often operate multiple production lines, integrate equipment from different vendors, manufacture diverse products, and generate vast amounts of operational data. Without a connected automation strategy, valuable information remains dispersed across isolated systems, making it difficult to identify trends, investigate deviations, or respond quickly to changing process conditions.

The consequences are familiar across the industry: extended troubleshooting cycles, slower investigations, inconsistent visibility across departments, increased manual effort, and missed opportunities for continuous improvement.^4,6

Automation addresses these challenges by bringing manufacturing information into a unified operational environment. It standardizes data collection, enables real-time monitoring, improves collaboration between production, engineering, maintenance, and quality teams, and provides the visibility needed to support faster, evidence-based decision-making. ^4,7

Reliable Process Automation: The Foundation of Manufacturing Excellence

Consistent manufacturing begins with consistent process control. Modern automation platforms ensure manufacturing processes are executed accurately and repeatedly, reducing process variability while improving operational stability. High-availability architectures, redundant controllers, and automated failover capabilities help maintain production continuity even during equipment or system failures, minimizing operational risk and reducing unplanned downtime.

Beyond productivity, reliable automation directly contributes to consistent product quality, regulatory compliance, and confidence in manufacturing performance. It also establishes the trusted operational environment required for digital manufacturing initiatives by ensuring that the data generated throughout production accurately reflects manufacturing conditions.^1,8

Reliable process automation therefore represents the first building block of an intelligent manufacturing ecosystem.

Creating Operational Visibility Through Connected Manufacturing

Manufacturing decisions are only as effective as the information supporting them. Operators, engineers, maintenance personnel, and quality teams all rely on timely access to process information to maintain efficient and compliant manufacturing operations. Modern supervisory platforms consolidate real-time process parameterssuch as temperature, pressure, flow, level, and other critical process variables, equipment status, alarms, events, and production information into centralized dashboards that provide a comprehensive view of manufacturing activities in real time.This enables different functions to access a common operational picture and respond more effectively to changing process conditions.

Rather than reacting after problems occur, teams can identify abnormal process conditions as they develop, coordinate responses across functions, and resolve issues before they affect production schedules or product quality.

Centralized operational visibility also improves communication between departments, reduces response times, and enables organizations to move from isolated equipment-level monitoring toward a connected understanding of manufacturing performance.^4,7

This shared operational perspective forms an essential component of digital manufacturing and creates the foundation for advanced analytics and continuous improvement.

Transforming Manufacturing Data into Actionable Intelligence

Every manufacturing operation continuously generates valuable information—from process parameters and equipment status to alarms, events, production records, and quality data. The challenge is no longer collecting this information; it is transforming it into meaningful insight.

Automation systems continuously capture operational data, while manufacturing historians preserve it in secure, centralized repositories that maintain accurate, time-stamped records of manufacturing activities. Over time, these records create a comprehensive operational history that supports trend analysis, process optimization, deviation investigations, root cause analysis, knowledge management, and continuous improvement.

Historical manufacturing data enables engineers to understand process behavior under different operating conditions, identify recurring issues, evaluate equipment performance, and make improvements based on evidence rather than assumptions.

Equally important, trusted manufacturing data supports regulatory expectations related to data integrity, electronic records, audit trails, and controlled system access.^2,3

When data are reliable, accessible, and properly contextualized, they become one of the organization’s most valuable strategic assets—and the essential foundation for digital intelligence.

Building a Secure and Connected Digital Infrastructure

As manufacturing operations become increasingly connected, the supporting digital infrastructure becomes just as important as the automation itself.

A resilient manufacturing environment depends on secure industrial networks, virtualized server infrastructure, controlled user access, network segmentation, and robust cybersecurity practices. Together, these technologies protect critical manufacturing systems while improving system availability, simplifying maintenance, supporting disaster recovery, and enabling future expansion.

Cybersecurity has become an integral component of pharmaceutical manufacturing. As operational technology becomes more connected with enterprise systems, organizations must ensure that manufacturing environments remain protected from cyber threats without compromising operational performance or regulatory compliance.⁹

A secure and scalable infrastructure enables organizations to confidently adopt new digital technologies while maintaining business continuity, data integrity, and system reliability.

In this way, digital infrastructure becomes the backbone that supports both today’s manufacturing operations and tomorrow’s digital transformation initiatives.

From Operational Data to Manufacturing Intelligence

Automation does much more than keep manufacturing processes running—it generates the information needed to understand, improve, and optimize them.

Every process, sensor, alarm, and equipment event contributes to a continuously growing body of manufacturing knowledge. Real-time monitoring enables production teams to detect deviations early and respond before they escalate into larger issues. Historical operational data allows engineering and quality teams to investigate equipment performance, identify recurring trends, understand process variability, and perform root cause analyses with greater confidence.^6,8

Instead of relying on fragmented information or manual data collection, manufacturers can build decisions around a complete and reliable operational picture. This approach shortens investigation timelines, improves process understanding, and supports continuous improvement.

Digital manufacturing maturity evolves through 3 interconnected stages: collecting trusted data, converting that data into operational understanding, and ultimately using advanced analytics to generate predictive intelligence. Automation enables each stage by ensuring that reliable information is continuously available throughout the manufacturing lifecycle.

Extending Automation Through IIoT, eBPR, and AI

Once a robust automation platform is in place, manufacturers can progressively introduce digital technologies that enhance operational efficiency, improve decision-making, and unlock greater value from manufacturing data.

The IIoT extends automation by connecting manufacturing equipment, utilities, sensors, and supporting systems into a unified digital ecosystem. This broader connectivity improves equipment monitoring, asset utilization, and operational visibility while enabling closer collaboration across production, engineering, maintenance, and quality functions. As organizations mature, IIoT also creates opportunities for predictive maintenance, equipment health monitoring, and real-time operational optimization.^7,10

eBPR further build on the automation foundation by capturing manufacturing information directly from process control systems. By reducing manual documentation and eliminating transcription errors, eBPR improves data accuracy, strengthens traceability, shortens batch review cycles, and enhances audit readiness while supporting regulatory expectations for electronic records and data integrity.^2,11,12

AI represents the next stage in the evolution of digital manufacturing. Unlike traditional automation, which focuses on executing processes, AI helps organizations understand, predict, and optimize them. Using trusted manufacturing data generated through automation, AI can identify process trends, compare batch records, analyze relationships between process variables, automate information retrieval, support deviation investigations, and generate operational insights that help manufacturing experts make faster and better-informed decisions.

However, AI is only as effective as the quality of the data it receives. Without reliable automation, standardized data collection, and robust governance, even the most advanced analytical models cannot produce dependable insights. AI should therefore be viewed not as a replacement for manufacturing expertise, but as a capability that enhances human decision-making through better use of trusted manufacturing information.

Together, IIoT, eBPR, and AI extend the value of automation, enabling manufacturers to move beyond operational control toward connected, intelligent, and increasingly predictive manufacturing.

Automation: The Foundation of Pharma 4.0

Pharma 4.0 is often associated with AI, advanced analytics, and highly connected manufacturing environments. Yet these capabilities do not exist in isolation—they are built upon a foundation of reliable automation.

The journey begins with consistent process execution and centralized operational visibility. As manufacturing systems become connected, they generate trusted, high-quality data that strengthens process understanding, supports investigations, and enables continuous improvement. This progression reflects the evolution of manufacturing maturity: organizations first establish reliable automated operations, then connect manufacturing systems to create enterprise-wide visibility, use trusted data for evidence-based decision-making, and ultimately adopt intelligent technologies that enable predictive manufacturing, proactive process optimization, and increasingly adaptive operations.

In this context, automation has evolved far beyond process control. It is now one of the pharmaceutical industry’s most important strategic enablers of digital manufacturing. By improving process consistency, strengthening data integrity, increasing operational visibility, and creating secure, connected manufacturing environments, automation enables organizations to produce high-quality medicines more efficiently while meeting increasingly demanding regulatory expectations.^2,4,8

The journey toward Pharma 4.0 is therefore not defined by the adoption of individual technologies, but by the creation of an integrated manufacturing ecosystem where automation, data, infrastructure, and intelligence work together to support continuous improvement and better decision-making. Organizations that continue to strengthen their automation maturity today will be best positioned to embrace intelligent manufacturing, accelerate innovation, and build resilient, future-ready operations for tomorrow.

References

1. Ministry of Health and Family Welfare, Government of India. Drugs (Amendment) Rules, 2023 — G.S.R. 922(E): Revised Schedule M, Good Manufacturing Practices and Requirements of Premises, Plant and Equipment for Pharmaceutical Products. December 28, 2023.
2. FDA. Data Integrity and Compliance With Drug CGMP: Questions and Answers — Guidance for Industry. FDA. December 2018.
3. Central Drugs Standard Control Organization (CDSCO). Implementation of Schedule M and WHO Technical Report Series. Circular, August 7, 2024.
4. International Society for Pharmaceutical Engineering (ISPE). Pharma 4.0™ Operating Model. ISPE Pharma 4.0™ Initiative.
5. FDA. 21 CFR Parts 210 and 211 — Current Good Manufacturing Practice for Finished Pharmaceuticals. U.S. Food and Drug Administration.
6. Weiss BA, Brundage MP, Tamm Y, Makila T, and Pellegrino J. Summary Report on the Industry Forum for Monitoring, Diagnostics, and Prognostics for Manufacturing Operations. NIST Advanced Manufacturing Series 100-23. National Institute of Standards and Technology, Gaithersburg, MD, 2019. doi: 10.6028/NIST.AMS.100-23.
7. Montgomery K, Candell R, Hany M, and Liu Y. Wireless User Requirements for the Factory Workcell. NIST Advanced Manufacturing Series 300-8r1. National Institute of Standards and Technology, 2021. doi: 10.6028/NIST.AMS.300-8r1/upd.
8. FDA. Process Validation: General Principles and Practices—Guidance for Industry. January 2011.
9. Stouffer K, Pease M, Tang C, Zimmerman T, Pillitteri V, Lightman S, Hahn A, Saravia S, Sherule A, and Thompson M. Guide to Operational Technology (OT) Security. NIST Special Publication 800-82 Revision 3. National Institute of Standards and Technology, 2023. doi: 10.6028/NIST.SP.800-82r3.
10. Diaz-Elsayed N, Hernandez L, Rajamani R, and Weiss B. Asset Condition Management: A Framework for Smart, Health-Ready Manufacturing Systems. Proceedings of the ASME 2020 15th International Manufacturing Science and Engineering Conference (MSEC2020), 2020.
11. FDA. Part 11, Electronic Records; Electronic Signatures — Scope and Application. Guidance for Industry. U.S. Food and Drug Administration.
12. International Society for Pharmaceutical Engineering (ISPE). GAMP® Good Practice Guide: Manufacturing Execution Systems (MES) – A Strategic and Program Management Approach. ISPE, February 2010.

About the Authors

M. Damodharan (CDO), PhD, is chief quality officer at Sai Life Sciences. He possesses more than 30 years of pharmaceutical industry experience. His vision to build future AI ready pharma organization, he is envisioned to apply AI and ML to improve pharmaceutical quality and productivity, leading impactful implementations such as manufacturing failure prediction models, and AI-driven retro synthesis for discovery.

Ajay Gabhale is assistant general manager-IT at Sai Life Sciences. He is an Automation and Digital Transformation professional in the pharmaceutical manufacturing industry expertise in process control systems, MES, IT/OT integration and convergence, industrial networking, and digital manufacturing technologies, leveraging automation, data analytics, Industrial IoT (IIoT), and AI-driven solutions to improve operational efficiency, process visibility, and data integrity while balancing innovation with regulatory compliance.